Lung disease and Pseudomonas aeruginosa (P. aeruginosa) airway colonization represent a major cause of morbidity and mortality in cystic fibrosis (CF). Human b-defensin (hBD)-1 is believed to play an important role in mucosal innate immunity in the lung. This study aimed to investigate whether three single-nucleotide polymorphisms (SNPs) in the 5 0 -untranslated region of DEFB1, G-52A, C-44G and G-20A were associated with P. aeruginosa airway colonization in CF. A total of 224 CF patients and 196 control subjects were studied. DEFB1 SNPs were characterized by restriction fragment length polymorphisms. Patients' sputum samples were collected and analyzed by standard methods. Single SNP analysis suggested that CF patients carrying the À52AA and the À20GG genotypes had a higher rate of P. aeruginosa airway colonization than patients homozygous and heterozygous for the À52G and À20A alleles (P ¼ 0.01 and P ¼ 0.007, respectively). A significant association between the ACG haplotype and chronic P. aeruginosa infection was also identified (odds ratio (95% confidence interval): 3.00 (1.42-6.36), P ¼ 0.004). These results indicate that variant alleles in DEFB1 might contribute to the colonization of P. aeruginosa in CF.
Introduction
Cystic fibrosis (CF) is the most common lethal autosomal-recessive disorder in the Caucasian population and is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. 1 Recurrent infections of the lower respiratory tract and chronic lung damage represent the most common causes of mortality in CF patients. The current pathophysiologic concept concerning CF lung disease holds that depletion of airway surface fluid, caused by defective chloride secretion and sodium hyperabsorption, results in breakdown of mucociliary transport, which favors bacterial infection and persistence. 2 Bacterial infection in CF is limited to a relatively restricted spectrum of pathogens of which Pseudomonas aeruginosa (P. aeruginosa) represents one of the most prevalent organisms. 3 This pathogen protects itself within a thick layer of alginate, leading to an exaggerated inflammatory response, which greatly contributes to the chronic lung damage characteristic of CF. However, human airways are endowed with numerous defense mechanisms to prevent microbial colonization by this, as well as other, pathogens. An important component of this defense system is represented by antimicrobial peptides present in the airway surface fluid called defensins. These are small cationic peptides divided into a and b groups, according to the positions of six conserved cysteine residues forming three intramolecular disulfide bonds. 4 b-Defensins show a broad spectrum of activity against Gram-positive and Gram-negative bacteria, fungi and viruses, 5 and also exhibit other functions, including potent chemotactic activity for immature dendritic cells and memory T cells. 6 Human b-defensins include b-defensin-1 (hBD-1), which is constitutively expressed in several epithelial tissues including the conducting and respiratory airways. 7 The role of defensins, as well as other antimicrobial peptides, in the pathogenesis of lung disease in CF remains to be fully elucidated. According to some authors, the activity of these antimicrobial peptides is inhibited by the high salt concentration in the airway surface fluid of CF patients, 8, 9 while others have indicated that the antimicrobial activity in airway surface fluid of CF patients is decreased independently of its salt concentration. 10 The finding that the severity of lung disease, in CF, does not correlate with the CFTR genotype has led to the hypothesis that other environmental and genetic factors could affect the lung phenotype. Therefore, the role of modifier genes has been proposed, in the last few years, by several authors. 11, 12 Genes coding for mannose-binding lectin, surfactant proteins, tumor necrosis factor-a, transforming growth factor-b, a 1 antitrypsin, nitric oxide synthase, have all been reported to act as modifier genes in CF lung disease. 11, 12 A role for b-defensin genes, as potential modifiers, has also been hypothesized. 13, 14 The h-BD1 gene (DEFB1; IIPGA Genetic Data) covers approximately 8 kb on chromosome 8p23.1 and is split into two exons. 4, 15 Three frequent single-nucleotide polymorphisms (SNPs) at positions À52G/A (rs1799946), À44C/G (rs1800972) and À20G/A (rs11362) in the 5 0 -untranslated region (UTR) of DEFB1 were described by Dork and Stuhrmann 16 in a cohort of German blood donors. The untranslated variants, identified by these authors, could influence hBD-1 expression or function.
The aim of the present study was to test the hypothesis that some SNPs located in the 5 0 -UTR of the DEFB1 gene might be related to the development of chronic P. aeruginosa infection and the severity of lung disease in patients with CF.
Results
A total of 224 patients and 196 controls were studied. Of the 224 patients with CF, 182 (81%) had the severe/severe CFTR genotype (carriers of classes I, II, III of gene mutations) and 42 patients (19%) had the mild (carriers of classes VI, V of gene mutations) and/or the unknown/ unknown CFTR genotype. Patients carrying the severe/severe CFTR genotype did not show an increased rate of colonization with P. aeruginosa, compared to subjects carrying the mild, unknown/unknown CFTR genotype (110 out of 153 (72%) vs 18 out of 22 (81%), P ¼ ns). During the study period, sputum samples were collected from 175 (78%) patients, of whom 128 (73%) showed P. aeruginosa airway colonization. Pulmonary function parameters were recorded in 157 (70%) patients (median forced expiratory volume in one second: 76% of predicted (range 20-126%)), and in 126 (80%) of whom microbiological data were also recorded (92 patients (73%) with chronic P. aeruginosa infection and 34 (27%) without such infection). Patients with chronic P. aeruginosa infection showed a significantly lower median forced expiratory volume in one second value than patients without such infection (71% of predicted (range 20-125%) vs 91% of predicted (range 62-119%), P ¼ 0.006).
The genotype-allele distribution for DEFB1 polymorphisms followed the Hardy-Weinberg equilibrium both in patients and controls. The three SNPs were in linkage disequilibrium (pairwise D 0 coefficient: 0.98 for G-52A and G-20A, r 2 ¼ 0.14; 0.84 for C-44G and G-20A, r 2 ¼ 0.18; 0.92 for G-52A and C-44G, r 2 ¼ 0.12; Po0.00001). In agreement with other studies, 16 ,17 the three SNPs in the 5 0 -UTR of the DEFB1 gene generated three main haplotypes in our population: GCA, ACG and GGG. Allele frequencies of each SNP and haplotype frequencies were similar between patients and healthy controls ( Table 1 ). The distribution of the three genotypes of the À52 (G/A) and À20 (G/A) SNPs was found to be significantly different in patients with chronic P. aeruginosa infection compared to subjects without such infection (Table 2 ). In fact, the polymorphic A allele at the À52 locus site of the DEFB1 gene was associated with an increased risk of P. aeruginosa chronic colonization (odds ratio (OR) adjusted for age 4.98, 95% confidence interval (CI) 1.40-11.90, P ¼ 0.01). Likewise, carriers of the G allele at the À20 locus site presented an increased risk of airway P. aeruginosa colonization than homozygous and heterozygous for the A allele (OR adjusted for age 2.96, 95% CI 1.03-8.47, P ¼ 0.007). Carrying the À44CC genotype was not related to an increased risk of colonization with P. aeruginosa as compared to carriers of the CG and the GG genotypes in our population (OR adjusted for age 0.62, 95% CI 0.41-0.93, P ¼ ns). Multivariate analysis showed that the relationship between chronic P. aeruginosa infection and genotypes studied was not dependent upon other confounding Table 2) . We found that carriers of the GA and AA genotypes at the À52 locus site of the DEFB1 gene had an increased risk of P. aeruginosa chronic colonization than carriers of the GG genotype (OR adjusted for age 3.21, 95% CI 1.12-9.23, P ¼ 0.03). Carrying the À44CC and the À20GG genotypes was not related to an increased risk of colonization with P. aeruginosa as compared to carriers of the À44CG/GG and the À20GA/AA genotypes, respectively, in this population (ORs adjusted for age 1.37, 95% CI 0.26-7.22 and 0.43, 95% CI 0.13-1.42, respectively; P ¼ ns). Moreover, in this group of CF patients, the ACG haplotype was also significantly associated with P. aeruginosa chronic infection (OR adjusted for age 2.70, 95% CI 1.15-6.36, P ¼ 0.02).
Discussion
The observation that CF patients with the same CFTR mutations often display different clinical phenotypes has led to studies investigating genes that might modify lung disease progression, such as those involved in innate immunity.
11,12,18,19 P. aeruginosa infection represents a major factor contributing to the progression of lung damage in CF. In keeping with other studies, 1-3 data emerging from the present investigation demonstrated that a large percentage (73%) of CF patients presented chronic airway colonization with P. aeruginosa, and that this infection negatively affected lung function. There were no differences in rates of colonization among patients with different CFTR genotypes. However, the most interesting result of our study was that some haplotypes of the 5 0 -UTR region of the DEFB1 gene were correlated with chronic P. aeruginosa infection in CF. In fact, in our population, the ACG haplotype was significantly associated with a higher rate of P. aeruginosa infection compared to GCA. Furthermore, we confirmed that this association was significant also in patients with the same severe/severe CFTR genotype, excluding that the CFTR gene mutations may affect the colonization ( Table 2) .
The role of DEFB1 polymorphisms in human infectious disease is supported by association studies that documented a significant correlation between the À44 (C/G) SNP in the 5 0 -UTR of the DEFB1 gene and the risk of HIV-1 infection, in an Italian pediatric population, 20 and with susceptibility to Candida carriage in type I diabetes. 21 In these studies, subjects carrying the CC genotype at the À44 locus site of the gene showed a greater risk of acquiring both types of infection. 20, 21 It is difficult to compare our results with those of the two above-mentioned studies, where the authors did not compute a haplotype analysis. Taken together, these studies support the role of DEFB1 gene polymorphisms in host susceptibility to infections and human disease.
Attempts to find an association between various DEFB1 gene polymorphisms, including those in the 5 0 -UTR, and CF lung disease severity in European populations have already been made by Vankeerberghen et al., 14 who sought a relationship between several DEFB1 SNPs and the age of first P. aeruginosa infection in CF patients. No correlation was found between h-BD1 common genetic variants and the outcome studied. However, these authors did not look at P. aeruginosa colonization in their cohort. Furthermore, in agreement with our data, they reported that DEFB1 polymorphisms were not related to lung function parameters. 14 Recently, Wallace et al. 22 found no association between the same 5 0 -UTR DEFB1 SNPs, lung function decline and susceptibility to infection, in healthy adult smokers.
In conclusion, our results support a role for DEFB1 in airway colonization by P. aeruginosa in CF patients. However, the precise relationship remains to be established as no association was found between the DEFB1 haplotypes studied and lung function parameters.
It is unlikely that a single modifier gene contributes to the severity of CF lung disease. More likely, the combination of a multitude of SNPs, in different genetic loci and genes, also coding for proteins that follow different pathways, might contribute to produce the highly variegated clinical CF phenotype. The identification of the untranslated variants in DEFB1 gene may contribute to a better understanding of the pathogenesis of this disease, the identification of subgroups of patients at risk for pulmonary damage and possibly to new therapeutic approaches. ), and the identification of mutations in the CFTR gene. 23, 24 The study protocol was approved by the local Ethics Committee. Clinical, biological and functional data were obtained retrospectively from patients' hospital records. The following information was collected: gender, age at diagnosis of CF, CFTR genotype, results of pulmonary function tests (median forced expiratory volume in one second expressed as percentages of predicted values) and exocrine pancreatic status. Sputum swabs were obtained from each patient during routine visits (most patients were regularly examined at 4-month intervals) as well as twice during hospitalization. Chronic P. aeruginosa infection was defined as the presence of P. aeruginosa in the sputum cultures in three consecutive samples collected in a 6-month period. 25 Informed consent to collect DNA was obtained from the participants, or, in case of minors, from parents or guardian.
Materials and methods

Molecular genetic methods
Genomic DNA was extracted from blood samples, and the SNPs at position À52 (a guanine to adenine nucleotide mutation), À44 (a cytosine to guanine nucleotide mutation) and À20 (a guanine to adenine nucleotide mutation) in the 5 0 -UTR of the DEFB1 gene were genotyped by use of PCR and restriction fragment length polymorphism, as described elsewhere. 14, 15 Processing of sputum samples, culture of P. aeruginosa and phenotypic analysis Sputum samples from all patients were mixed with equal volumes of 1% dithiothreitol (Merck, Darmstadt, Germany) before incubation at 371 C for 30 min. All specimens were examined microscopically and cultured. Isolates obtained from the samples were identified by the Phoenix (Becton Dickinson, Sparks, MA, USA) automated system.
Statistical analysis
Statistical analyses were performed using SPSS for Windows software (SPSS Inc., version 11.0, Chicago, IL, USA). Data are expressed as percentages or median and range. Pearson w 2 or Fisher's exact test and w 2 for linear trend tests were used for categorical data. Differences between groups were assessed with the non-parametric Kruskal-Wallis test. Deviation of the expected values from Hardy-Weinberg equilibrium was also evaluated by the Fisher's exact test. To investigate the pattern of linkage disequilibrium in the DEFB1 locus, the pairwise linkage disequilibrium coefficient was assessed for each SNP pair and expressed as D 0 and r
2
. Logistic regression analyses were calculated to determine the influence of confounding variables (gender, birth date, age at diagnosis of CF, CFTR genotype and pancreatic status) upon the outcome, respectively. Haplotypes were inferred from DEFB1 5 0 -UTR SNPs by Bayesian methods as implemented in the Phase software. 26 All haplotype analyses were performed using the family-based association test method, which tests for haplotype-phenotype association. 27 Results were considered statistically significant when the probability of findings occurring by chance was less than 5% (Po0.05).
